Healthleap Secures 38 Million Dollars in Funding to Expand Patient Screening Platform in Hospitals
Healthleap has raised $38 million in seed and Series A funding to expand its hospital patient-screening platform. The startup secured an $8 million seed round co-led by Sequoia Capital and First Round Capital, alongside a $30 million Series A led by Hummingbird Ventures.
Healthleap has raised $38 million in seed and Series A funding to expand its hospital patient-screening platform. The startup secured an $8 million seed round co-led by Sequoia Capital and First Round Capital, alongside a $30 million Series A led by Hummingbird Ventures. Founded in South Africa in 2022 by siblings Jemima and Josiah Meyer, the company plugs into hospital electronic health record systems.
Its platform uses language models to extract notes from clinicians alongside structured data like lab results and vital signs. The software then calculates risk scores to flag patients who may suffer from conditions like malnutrition or delirium, though it does not provide official diagnoses. The platform currently operates in more than 50 hospitals, including Penn Medicine, Cedars-Sinai, and Emory Healthcare.
Healthleap sells three-year contracts priced by licensed bed count alongside an outcome-based pricing model. The startup plans to use the new capital to hire engineering, product, and sales staff while expanding its software to cover more than 40 major health conditions.
WireUnWired turns the supplied report into a clearer brief, preserves the original publisher and author details, and adds relevant context without hiding where the information came from.
Relevant WireUnWired coverage is connected so one story can lead into the larger technology context.
Original publication: 7 October 2026 20:37